Regulacje i polityka gospodarcza · 07/12/2000
NIH to Grant Exclusive License for Pancreatic Cell Research
The National Institutes of Health is considering granting an exclusive worldwide license to PanCel Corp. to develop therapeutic applications using adult pancreatic cells for diabetes treatment, based on patents and a foreign patent application.